One of Elon Musk's DOGE Staffers Used to Sell Ketamine Professionally
Briefly

The article explores the controversial backgrounds of staff at Elon Musk's Department of Government Efficiency, particularly focusing on Alexandra Beynon, a former head of engineering at a ketamine therapy startup called Mindbloom. As Mindbloom aims to provide at-home ketamine treatment for mental health, questions arise about the oversight and safety of such therapies, especially after a report indicating significant misuse of at-home ketamine. The article underscores the need for proper therapeutic guidance in this burgeoning industry, noting that some patients may struggle without adequate support during treatment.
In 2023, a study found that 55% of respondents misused at-home ketamine treatments, underscoring concerns about the safety and regulation in the psychedelic therapy space.
Mindbloom's cofounder noted that 35% of applicants are denied treatment, typically due to substance abuse issues, highlighting the need for careful patient selection.
Read at Futurism
[
|
]